About Enhancer
| Enhancer ID: | E_03213 |
| Species: | Homo sapiens |
| Position : | chr11:5301862-5302715   |
| Year: | 2015 |
| Title: | Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 26501517 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | K-562 |
| CVCL ID: | CVCL_0004 |
| Cell Type: | erythroid-like cell |
| Experiment Type: | Functional perturbation assay; Enhancer chromatin-state assay; Epigenome-editing assay |
| High Throughput Method: | RNA-seq; FLAG-dCas9 ChIP-seq; H3K9me3 ChIP-seq; DNase-seq |
| Low Throughput Method: | dCas9-KRAB CRISPRi; sgRNA targeting; ChIP-qPCR; RT-qPCR; CRISPR-Cas9 |
About Target Gene
| Target gene : | HBB |
About TF
| TF name : | NA |
About Regulatory State
| Regulatory State : | Repressed |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer Associated Network
Overlapping Enhancers (hg19)
28 found
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_02356 | chr11:5222500-5323700 | blood | erythroid cell | NA |
| E_02363 | chr11:5222500-5323700 | blood | erythroid cell | NA |
| E_02364 | chr11:5222500-5323700 | blood | erythroid cell | NA |
| E_02365 | chr11:5222500-5323700 | blood | erythroid cell | NA |
| E_03631 | chr11:5301485-5302895 | blood | malignant cell | NA |
| E_03230 | chr11:5301600-5302400 | blood / hematopoietic system | NA | NA |
| E_03231 | chr11:5301600-5302400 | blood / hematopoietic system | NA | NA |
| E_03232 | chr11:5301600-5302400 | blood / hematopoietic system | NA | NA |
| E_03070 | chr11:5301801-5302175 | pleural effusion | erythroid lineage cell | NA |
| E_03071 | chr11:5301801-5302175 | pleural effusion | erythroid lineage cell | NA |
| E_03200 | chr11:5301862-5302715 | blood | malignant cell | NA |
| E_03201 | chr11:5301862-5302715 | blood | malignant cell | NA |
| E_03202 | chr11:5301862-5302715 | blood | malignant cell | NA |
| E_03203 | chr11:5301862-5302715 | blood | malignant cell | NA |
| E_03204 | chr11:5301862-5302715 | blood | malignant cell | NA |
| E_03205 | chr11:5301862-5302715 | blood | malignant cell | NA |
| E_03206 | chr11:5301862-5302715 | blood | malignant cell | NA |
| E_03207 | chr11:5301862-5302715 | blood | malignant cell | NA |
| E_03210 | chr11:5301862-5302715 | blood | erythroid-like cell | NA |
| E_03211 | chr11:5301862-5302715 | blood | erythroid-like cell | NA |
| E_03212 | chr11:5301862-5302715 | blood | erythroid-like cell | NA |
| E_04277 | chr11:5301862-5302715 | blood | malignant cell | NA |
| E_04382 | chr11:5301862-5302715 | blood | malignant cell | NA |
| E_04567 | chr11:5301862-5302715 | blood | myeloid cell | NA |
| E_04237 | chr11:5301983-5302001 | pleural effusion | erythroid lineage cell | NA |
| E_04238 | chr11:5301983-5302001 | pleural effusion | erythroid lineage cell | NA |
| E_04245 | chr11:5301983-5302001 | uterine cervix | epithelial cell | NA |
| E_04246 | chr11:5301983-5302001 | uterine cervix | epithelial cell | NA |
Expression of Target Genes for the Enhancer